Sanz-Alvarez, M., Martin-Aparicio, E., Luque, M., Zazo, S., Martinez-Useros, J., Eroles, P., . . . Rojo, F. (2021). The Novel Oral mTORC1/2 Inhibitor TAK-228 Reverses Trastuzumab Resistance in HER2-Positive Breast Cancer Models.
Citación estilo ChicagoSanz-Alvarez, M., et al. The Novel Oral MTORC1/2 Inhibitor TAK-228 Reverses Trastuzumab Resistance in HER2-Positive Breast Cancer Models. 2021.
Cita MLASanz-Alvarez, M., et al. The Novel Oral MTORC1/2 Inhibitor TAK-228 Reverses Trastuzumab Resistance in HER2-Positive Breast Cancer Models. 2021.
Precaución: Estas citas no son 100% exactas.